Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population
Khadijah Basheer, Evelyn Mensah, Tina Khanam, Neda Minakaran Ophthalmology Department, Central Middlesex Hospital, London, UK Aim: To compare the visual outcomes of an urban population with age-related macular degeneration (AMD) undergoing ranibizumab monotherapy to the results from major clinical...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d29dcaede704a64b05da8279d4ce59c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1d29dcaede704a64b05da8279d4ce59c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1d29dcaede704a64b05da8279d4ce59c2021-12-02T01:06:09ZVisual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population1177-5483https://doaj.org/article/1d29dcaede704a64b05da8279d4ce59c2015-05-01T00:00:00Zhttp://www.dovepress.com/visual-outcomes-of-age-related-macular-degeneration-patients-undergoin-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Khadijah Basheer, Evelyn Mensah, Tina Khanam, Neda Minakaran Ophthalmology Department, Central Middlesex Hospital, London, UK Aim: To compare the visual outcomes of an urban population with age-related macular degeneration (AMD) undergoing ranibizumab monotherapy to the results from major clinical trials.Procedures: Prospective data was collected from 164 wet AMD patients receiving intravitreal ranibizumab. Visual acuities were obtained with the Early Treatment Diabetic Retinopathy Study chart. All patients underwent a loading phase of three monthly treatments of ranibizumab. Patients were monitored monthly using a retreatment criterion. Treatment was further individualized by sequentially lengthening follow-up intervals when stable.Results: At 12 and 24 months, respectively, the percentage of eyes that maintained vision was 91% and 88.6%. We found that 20.3% of eyes had improved vision at 12 months and 20% at 24 months. At 12 months, 8.3% of eyes’ vision worsened and 12% worsened at 24 months.Conclusion: Individualized ranibizumab monotherapy is effective in preserving vision in wet AMD and follows the same trends as the pivotal trials. Keywords: visual acuity, comparison of age-related macular degeneration treatment trials, choroidal neovascular membraneBasheer KMensah EKhanam TMinakaran NDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 959-965 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Basheer K Mensah E Khanam T Minakaran N Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
description |
Khadijah Basheer, Evelyn Mensah, Tina Khanam, Neda Minakaran Ophthalmology Department, Central Middlesex Hospital, London, UK Aim: To compare the visual outcomes of an urban population with age-related macular degeneration (AMD) undergoing ranibizumab monotherapy to the results from major clinical trials.Procedures: Prospective data was collected from 164 wet AMD patients receiving intravitreal ranibizumab. Visual acuities were obtained with the Early Treatment Diabetic Retinopathy Study chart. All patients underwent a loading phase of three monthly treatments of ranibizumab. Patients were monitored monthly using a retreatment criterion. Treatment was further individualized by sequentially lengthening follow-up intervals when stable.Results: At 12 and 24 months, respectively, the percentage of eyes that maintained vision was 91% and 88.6%. We found that 20.3% of eyes had improved vision at 12 months and 20% at 24 months. At 12 months, 8.3% of eyes’ vision worsened and 12% worsened at 24 months.Conclusion: Individualized ranibizumab monotherapy is effective in preserving vision in wet AMD and follows the same trends as the pivotal trials. Keywords: visual acuity, comparison of age-related macular degeneration treatment trials, choroidal neovascular membrane |
format |
article |
author |
Basheer K Mensah E Khanam T Minakaran N |
author_facet |
Basheer K Mensah E Khanam T Minakaran N |
author_sort |
Basheer K |
title |
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
title_short |
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
title_full |
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
title_fullStr |
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
title_full_unstemmed |
Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
title_sort |
visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/1d29dcaede704a64b05da8279d4ce59c |
work_keys_str_mv |
AT basheerk visualoutcomesofagerelatedmaculardegenerationpatientsundergoingintravitrealranibizumabmonotherapyinanurbanpopulation AT mensahe visualoutcomesofagerelatedmaculardegenerationpatientsundergoingintravitrealranibizumabmonotherapyinanurbanpopulation AT khanamt visualoutcomesofagerelatedmaculardegenerationpatientsundergoingintravitrealranibizumabmonotherapyinanurbanpopulation AT minakarann visualoutcomesofagerelatedmaculardegenerationpatientsundergoingintravitrealranibizumabmonotherapyinanurbanpopulation |
_version_ |
1718403302051282944 |